Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients

Massimo Fantoni; Roberto Cauda; Simona Di Giambenedetto; Massimiliano Fabbiani; Pierfrancesco Grima; Iuri Fanti; Manuela Colafigli; Alessandro D'Avino; Annalisa Mondi; Alberto Borghetti; Mauro Zaccarelli; Mattia Prosperi

doi:10.1186/1471-2334-14-26

Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients

Massimo Fantoni, Roberto Cauda, Simona Di Giambenedetto, Massimiliano Fabbiani, Pierfrancesco Grima, Iuri Fanti, Manuela Colafigli, Alessandro D'Avino, Annalisa Mondi, Alberto Borghetti, Mauro Zaccarelli, Mattia Prosperi

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

13 Citazioni (Scopus)

Abstract

Efavirenz (EFV) administration is still controversial for its high rates of interruption mainly related to central nervous system side effects (CNS-SE). Aim of the study was to define if single tablet regimen (STR) as compared to bis-in-die (BID) or once-daily (OD) with ≥2 pills-a-day EFV formulations reduced the risk of interruption.

Lingua originale	English
pagine (da-a)	26-26
Numero di pagine	1
Rivista	BMC Public Health
Volume	14
DOI	https://doi.org/10.1186/1471-2334-14-26
Stato di pubblicazione	Pubblicato - 2014

Keywords

Efavirenz
antiretroviral
nervous system
therapy

Accesso al documento

10.1186/1471-2334-14-26

Altri file e collegamenti

Link a IRIS PubliCatt

Fingerprint Entra nei temi di ricerca di 'Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients'. Insieme formano una fingerprint unica.

Cita questo

Fantoni, M., Cauda, R., Di Giambenedetto, S., Fabbiani, M., Grima, P., Fanti, I., Colafigli, M., D'Avino, A., Mondi, A., Borghetti, A., Zaccarelli, M., & Prosperi, M. (2014). Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients. BMC Public Health, 14, 26-26. https://doi.org/10.1186/1471-2334-14-26

Fantoni, Massimo ; Cauda, Roberto ; Di Giambenedetto, Simona ; Fabbiani, Massimiliano ; Grima, Pierfrancesco ; Fanti, Iuri ; Colafigli, Manuela ; D'Avino, Alessandro ; Mondi, Annalisa ; Borghetti, Alberto ; Zaccarelli, Mauro ; Prosperi, Mattia. / Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients. In: BMC Public Health. 2014 ; Vol. 14. pagg. 26-26.

@article{264b75d47f844c1aaf8f3aed7175d5da,

title = "Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy na{\"i}ve or switching for simplification HIV-infected patients",

abstract = "Efavirenz (EFV) administration is still controversial for its high rates of interruption mainly related to central nervous system side effects (CNS-SE). Aim of the study was to define if single tablet regimen (STR) as compared to bis-in-die (BID) or once-daily (OD) with ≥2 pills-a-day EFV formulations reduced the risk of interruption.",

keywords = "Efavirenz, antiretroviral, nervous system, therapy, Efavirenz, antiretroviral, nervous system, therapy",

author = "Massimo Fantoni and Roberto Cauda and {Di Giambenedetto}, Simona and Massimiliano Fabbiani and Pierfrancesco Grima and Iuri Fanti and Manuela Colafigli and Alessandro D'Avino and Annalisa Mondi and Alberto Borghetti and Mauro Zaccarelli and Mattia Prosperi",

year = "2014",

doi = "10.1186/1471-2334-14-26",

language = "English",

volume = "14",

pages = "26--26",

journal = "BMC Public Health",

issn = "1471-2458",

publisher = "BIOMED CENTRAL LTD, MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON, ENGLAND, W1T 4LB",

}

Fantoni, M , Cauda, R , Di Giambenedetto, S, Fabbiani, M, Grima, P, Fanti, I, Colafigli, M, D'Avino, A, Mondi, A, Borghetti, A, Zaccarelli, M & Prosperi, M 2014, 'Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients', BMC Public Health, vol. 14, pagg. 26-26. https://doi.org/10.1186/1471-2334-14-26

Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients. / Fantoni, Massimo ; Cauda, Roberto ; Di Giambenedetto, Simona; Fabbiani, Massimiliano; Grima, Pierfrancesco; Fanti, Iuri; Colafigli, Manuela; D'Avino, Alessandro; Mondi, Annalisa; Borghetti, Alberto; Zaccarelli, Mauro; Prosperi, Mattia.

In: BMC Public Health, Vol. 14, 2014, pag. 26-26.

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

TY - JOUR

T1 - Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients

AU - Fantoni, Massimo

AU - Cauda, Roberto

AU - Di Giambenedetto, Simona

AU - Fabbiani, Massimiliano

AU - Grima, Pierfrancesco

AU - Fanti, Iuri

AU - Colafigli, Manuela

AU - D'Avino, Alessandro

AU - Mondi, Annalisa

AU - Borghetti, Alberto

AU - Zaccarelli, Mauro

AU - Prosperi, Mattia

PY - 2014

Y1 - 2014

N2 - Efavirenz (EFV) administration is still controversial for its high rates of interruption mainly related to central nervous system side effects (CNS-SE). Aim of the study was to define if single tablet regimen (STR) as compared to bis-in-die (BID) or once-daily (OD) with ≥2 pills-a-day EFV formulations reduced the risk of interruption.

AB - Efavirenz (EFV) administration is still controversial for its high rates of interruption mainly related to central nervous system side effects (CNS-SE). Aim of the study was to define if single tablet regimen (STR) as compared to bis-in-die (BID) or once-daily (OD) with ≥2 pills-a-day EFV formulations reduced the risk of interruption.

KW - Efavirenz

KW - antiretroviral

KW - nervous system

KW - therapy

KW - Efavirenz

KW - antiretroviral

KW - nervous system

KW - therapy

UR - http://hdl.handle.net/10807/50891

U2 - 10.1186/1471-2334-14-26

DO - 10.1186/1471-2334-14-26

M3 - Article

VL - 14

SP - 26

EP - 26

JO - BMC Public Health

JF - BMC Public Health

SN - 1471-2458

ER -